Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · IEX Real-Time Price · USD
20.69
+0.18 (0.88%)
At close: May 17, 2024, 4:00 PM
19.66
-1.03 (-4.98%)
After-hours: May 17, 2024, 4:40 PM EDT
Longboard Pharmaceuticals Market Cap
Longboard Pharmaceuticals has a market cap or net worth of $807.35 million as of May 17, 2024. Its market cap has increased by 255.82% in one year.
Market Cap
807.35M
Enterprise Value
490.29M
1-Year Change
255.82%
Ranking
Category
Stock Price
$20.69
Market Cap Chart
Since the IPO on March 12, 2021, Longboard Pharmaceuticals's market cap has increased from $270.67M to $807.35M, an increase of 198.28%. That is a compound annual growth rate of 40.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 804.40M | 0.88% |
| May 16, 2024 | 797.40M | -2.98% |
| May 15, 2024 | 821.90M | 3.88% |
| May 14, 2024 | 791.20M | 2.10% |
| May 13, 2024 | 774.90M | -0.95% |
| May 10, 2024 | 782.30M | -8.50% |
| May 9, 2024 | 855.00M | 1.34% |
| May 8, 2024 | 843.70M | -1.56% |
| May 7, 2024 | 857.10M | 7.02% |
| May 6, 2024 | 800.90M | -3.63% |
| May 3, 2024 | 831.10M | -6.29% |
| May 2, 2024 | 886.90M | 12.14% |
| May 1, 2024 | 790.90M | 3.09% |
| Apr 30, 2024 | 767.20M | 0.34% |
| Apr 29, 2024 | 764.60M | 7.64% |
| Apr 26, 2024 | 710.30M | 2.45% |
| Apr 25, 2024 | 693.30M | -2.53% |
| Apr 24, 2024 | 711.30M | -2.57% |
| Apr 23, 2024 | 730.10M | 8.58% |
| Apr 22, 2024 | 672.40M | 7.05% |
| Apr 19, 2024 | 628.10M | -3.18% |
| Apr 18, 2024 | 648.70M | 5.94% |
| Apr 17, 2024 | 612.30M | -6.85% |
| Apr 16, 2024 | 657.30M | - |
| Apr 15, 2024 | 657.30M | -4.95% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HealthStream | 831.69M |
| Immunome | 828.17M |
| Aurinia Pharmaceuticals | 825.22M |
| Canopy Growth | 823.95M |
| Nuvation Bio | 820.61M |
| CareDx | 802.35M |
| Arcturus Therapeutics Holdings | 800.14M |
| Cytek Biosciences | 799.45M |